These findings suggest that the growth inhibitory effect exerted by ARI on metastatic cells and CSCs may occur through different signaling pathways, as observed in other cancer cells upon exposure to azacitidine or decitabine in combination with FAS-ligand [56]. Here, FAS is linked to cancer.